Neurocrine Biosciences Inc

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC NBIX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

722,476

Value ($000)

102,469

Weight

0.0%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	102,469	0.0%	722,476	12/31/2025
2025 Q3	11/14/2025	107,424	0.0%	765,237	9/30/2025
2025 Q2	8/14/2025	174,412	0.0%	1,387,635	6/30/2025
2025 Q1	5/19/2025	128,226	0.0%	1,159,367	3/31/2025
2024 Q4	2/14/2025	146,068	0.0%	1,070,096	12/31/2024
2024 Q3	11/14/2024	103,032	0.0%	894,217	9/30/2024
2024 Q2	8/14/2024	125,564	0.0%	912,064	6/30/2024
2024 Q1	5/15/2024	82,673	0.0%	599,424	3/31/2024
2023 Q4	2/14/2024	81,356	0.0%	617,453	12/31/2023
2023 Q3	11/13/2023	66,295	0.0%	589,291	9/30/2023
2023 Q2	8/11/2023	57,582	0.0%	568,878	6/30/2023
2023 Q1	5/15/2023	57,582	0.0%	568,878	3/31/2023
2022 Q4	2/14/2023	64,810	0.0%	542,612	12/31/2022
2022 Q3	11/14/2022	54,595	0.0%	514,026	9/30/2022
2022 Q2	8/12/2022	48,568	0.0%	498,238	6/30/2022
2022 Q1	5/16/2022	48,335	0.0%	515,568	3/31/2022
2021 Q4	2/14/2022	29,841	0.0%	350,370	12/31/2021
2021 Q3	11/15/2021	26,311	0.0%	274,330	9/30/2021
2021 Q2	8/16/2021	24,988	0.0%	256,764	6/30/2021
2021 Q1	5/14/2021	41,353	0.0%	425,226	3/31/2021
2020 Q4	3/1/2021	64,312	0.0%	670,965	12/31/2020
2020 Q3	11/13/2020	54,635	0.0%	568,164	9/30/2020
2020 Q2	8/14/2020	65,973	0.0%	540,761	6/30/2020
2020 Q1	5/15/2020	41,447	0.0%	478,880	3/31/2020
2019 Q4	2/14/2020	55,066	0.0%	512,289	12/31/2019
2014 Q1	5/23/2014	14,327	0.0%	889,898	3/31/2014
2013 Q4	1/31/2014	6,565	0.0%	702,898	12/31/2013